Designing of Nanocomposite model structure using Gallic acid and Ellagic acid with four different metals
Abstract
Bioflavonoids are now being an attraction of research for a couple of decades due to its immense application in therapeutics. To apply these flavonoids as a potential therapeutic drug in medical field, a vehicle is required to increase their retention in physiological conditions. Nanoparticles have come up with several unique properties to act as medium for drug delivery system. Hence, the formulation of nanoparticle – drug composite and their study has become mandatory today. Here we selected Gallic acid and its dimer Ellagic acid as drug molecules for having several applications in therapeutics that can be interacted with a metal nanoparticle. Twelve metals have been considered for study of interaction with mentioned drug molecules to construct nanoparticle–drug nanocomposite model structure by computational approach. All structures were subjected to energy minimization for reaching most stable structure. By considering all structures, cadmium (Cd) exhibited the most stable nanocomposite structure with Gallic acid and Ellagic acid as the composites contained lowest energy levels. It was also found that meta positioned –OH of Gallic acid is preferably the best suitable attachement site for metal atom and the same for Ellagic acid was found to be at corresponding 2 and 7 positioned –OH groups
Keywords: Flavonoids, Nanoparticles, Gallic acid, Ellagic acid and Avogadro software.
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Debraj Hazra, Doyel Chatterjee, Rajat Pal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license unless indicated otherwise in a credit line to the material. If the material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/ licenses/by/4.0/